Nataliya G. Brazovskaya

Nataliya G. Brazovskaya

Auto-generated profile, based on publicly available information

Nataliya G. Brazovskaya

Siberian State Medical University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
IDI. V. Dolgalev
I. V. Dolgalev
NBN. G. Brazovskaya
N. G. Brazovskaya
AIA. Yu. Ivanova
A. Yu. Ivanova
ASA. Yu. Shipkhineeva
A. Yu. Shipkhineeva
PBP. M. Bogaychuk
P. M. Bogaychuk
Aim.To study the influence of arterial hypertension (AH), smoking, and their combination on the risk of all cause and cardiovascular mortality.Material and methods. We conducted a 27-year cohort prospective study of the unorganized population of Tomsk (916 women and 630 men aged 20-59 years). At the first stage, we studied the prevalence of AH and smoking (1998-1991), at the second (2015) — the effect of these risk factors (RF) and their combination on the risk of all cause and cardiovascular mortality. AH was diagnosed at a blood pressure level of >140/90 mmHg and <140/90 mm Hg in individuals taking antihypertensive drugs. Smokers were individuals who smoked at least 1 cigarette per day and quit smoking less than one year ago.Results.The study found a significant effect of AH and smoking on mortality: the relative risk (RR) of all-cause mortality in people with hypertension was 2,2, in smokers — 2,3, in those with a combination of RF — 5,0. The RR of cardiovascular mortality in AH individuals was 3,4, in smokers — 1,6, in smoking men and women suffering from AH — 5,2. An increase in the risk of all-cause mortality in people with AH and smoking was observed in all gender-age groups. Smoking was found to increase the risk of all-cause mortality in individuals with high levels of blood pressure by 2,1 times compared with non-smoking hypertensive patients. It reduces the chances of a 27-year survival rate to 64,4%, and more so in the youngest (20-39 years) age group (RR — 3,9). Multivariate analysis showed that AH and smoking make the most significant contribution to the formation of mortality compared to other modifiable RFs.Conclusion.We found that AH and smoking are among the most influential RFs, and their combination increases the RR of all-cause mortality by 5,0 times (cardiovascular — 5,2 times). We also determined an additional risk of smoking in individuals suffering from AH to the all-cause mortality.

1 January 2019 in Social Aspects of Population Health
Verified
Journal Article
Closed access
NBN.G. Brazovskaya
N.G. Brazovskaya
IDI.A. Deev
I.A. Deev
ОКОльга Сергеевна Кобякова
Ольга Сергеевна Кобякова
PBP.M. Bogaichuk
P.M. Bogaichuk
NYN.D. Yarovoy
N.D. Yarovoy
SBS.V. Baranovskaya
S.V. Baranovskaya
???? ??????: ?????????? ??????? ??????? ???????? ??????????? ?????? ?? ?????? ?????????? ?? ???????????????? ??? ?????????? ???????????? ?? ????????? ???????? ???????? ??????????? ?????.

27 December 2019 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
IDI. V. Dolgalev
I. V. Dolgalev
NBN. G. Brazovskaya
N. G. Brazovskaya
AIA. Yu. Ivanova
A. Yu. Ivanova
ASA. Yu. Shipkhineeva
A. Yu. Shipkhineeva
PBP. M. Bogajchuk
P. M. Bogajchuk
Aim .  To study influence of hypertension, overweight, hypertriglyceridemia and their combinations for all-cause and cardiovascular mortality risk formation. Methods . The prevalence of hypertension, overweight and hypertriglyceridemia was studied (1988-1991) by 27-year prospective cohort study of unorganized population of Tomsk (1546 persons – 916 female and 630 male). The predictive value of these risk factors for all-cause and cardiovascular mortality risk formation were researched in 2015. Hypertension was diagnosed in persons with blood pressure greater or equal to 140/90 mm Hg, overweight was diagnosed in people with body mass index 25 kg/m 2 , hypertriglyceridemia was diagnosed in individuals having high blood level of triglycerides (greater or equal to 1.7). Results . Influence of hypertension for all-cause (relative risk (RR) 2.2) and cardiovascular mortality (RR 3.38) risk formation was detected. A hypertension related elevation of mortality risk was observed both among women and men and in all age groups with the exception of men 40-59 years (the results for cardiovascular mortality in these persons was statistically insignificant). We established that hypertension had the independent significant contribution for mortality risk formation. It is shown that RR of all-cause mortality 1.25 times (cardiovascular mortality 1.8 times) more in overweight persons. Increase of relative mortality risk was detected in overweight women, especially in women 20-39 years old. Hypertriglyceridemia increases relative risk of all-cause mortality 1.46 times, relative risk of cardiovascular mortality 2.15 times, especially in individuals 40-59 years old. It was revealed that hypertriglyceridemia is significant risk factor for all-cause mortality formation only in women. Combination of hypertension and overweight increases the risk of all-cause mortality 2.23 times and the risk of cardiovascular mortality 4.0 times, combination of hypertension and hypertriglyceridemia – 2.83 and 5.06 times, combination of overweight and hypertriglyceridemia – 1.73 and 2.99 times, respectively. We detected the additional risk of hypertriglyceridemia in individuals with overweight for all-cause (RR 1.53) and cardiovascular (RR 2.18) mortality risk formation compared with overweight persons with normal level of triglycerides and also the additional risk of hypertriglyceridemia (RR 1.51 and 2.04, respectively) in individuals with hypertension compared with normotensive persons (p<0,05). The additional risk of overweight in individuals with hypertension for all-cause mortality was found only in women (RR 3.23). Conclusion . The independent significant impact of hypertension for all-cause and cardiovascular mortality risk formation was revealed by the results of 27-year prospective study. Combination of hypertension and hypertriglyceridemia increases the risk of all-cause mortality 2.8 times and the risk of cardiovascular mortality 5.1 times, combination of hypertension and overweight – 2.2 and 4 times, combination of overweight and hypertriglyceridemia – 1.7 and 3 times, respectively. We detected the additional risk of hypertriglyceridemia for all-cause mortality in overweight people (RR 1.5) and in individuals with hypertension (RR 1.5). Also, the additional risk of hypertriglyceridemia for cardiovascular mortality risk formation in overweight people (RR 2.2) and in persons with hypertension (RR 2.0) was found.

11 August 2019 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
EKEkaterina Koroleva
Ekaterina Koroleva
VAV. M. Alifirova
V. M. Alifirova
ALA. V. Latypova
A. V. Latypova
SCS. V. Cheban
S. V. Cheban
VOV. A. Ott
V. A. Ott
NKN. G. Kataeva
N. G. Kataeva
This literature review is devoted to the study of recent advances in the field of neurorehabilitation using robotic technologies. Objective: to study best practices of applying robotic rehabilitation technologies in stroke patients, its clinical efficacy and influence on the molecular mechanisms of neuroplasticity. Keywords were searched in the Web of Science, Core Collection, Scopus and PubMed databases.Results.Robotic neurorehabilitation occupies a certain place in the comprehensive rehabilitation of patients with motor deficiency after stroke. An interdisciplinary patient-oriented approach and consistency at all stages of medical rehabilitation are especially important when using rehabilitation methods that implement advances in robotics and information technologies in patients after stroke. Rehabilitation with the use of high-tech computerized rehabilitation systems operating in the biofeedback mode is one of the promising areas and requires further neurophysiological and laboratory studies to create scientifically based methodological approaches. It will have great social significance and tangible economic effects from improving the quality of neurorehabilitation and reducing its duration.

23 April 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
MNM.A. Nikitina
M.A. Nikitina
EKEkaterina Koroleva
Ekaterina Koroleva
NBN.G. Brazovskaya
N.G. Brazovskaya
ABA.S. Boyko
A.S. Boyko
LLLyudmila Levchuk
Lyudmila Levchuk
VAV.M. Alifirova
V.M. Alifirova
OBJECTIVE To evaluate the clinical and laboratory correlation of biomarkers with anti- and pro-apoptotic activity with the severity of motor and non-motor symptoms depending on the progression rate of Parkinson’s disease (PD). MATERIAL AND METHODS A wide range of non-motor symptoms (emotional-affective, cognitive, psychotic and behavioral disorders, fatigue, sleep disorders and autonomic disorders) was evaluated using validated scales and a number of serum neuromarkers responsible for neuroplasticity and neuronal survival processes (BDNF, PDGF, cathepsin D) in 71 patients with PD (mean age 65 (55; 70) years, disease duration 7 (4; 9) years, age of onset 57 (49; 62) years). RESULTS The concentration of biomarkers (BDNF, PDGF and cathepsin D) was the lowest in the group of patients with a rapid PD progression rate (p<0.001, p=0.001 and p=0.031, respectively), the severity of motor and most non—motor symptoms was higher (p=0.023 and p=0.001, respectively) compared to middle and slow progression rate. There were correlations between BDNF concentration and the severity of depression (r=–0.63, p<0.001), apathy (r=–0.48, p<0.001), impulsive behavioral disorders (r=0.500, p<0.001), level of cognitive functions (r=0.54, p<0.001), motor symptoms (r=–0.43, p<0.001); between PDGF level and the severity of motor manifestations of PD (r=–0.30, p=0.011), depression (r=–0.70, p<0.001), apathy (r=–0.460, p<0.001), the degree of severity of behavioral disorders (r=0.742, p<0.001). No significant correlations were observed between the level of cathepsin D and the severity of clinical manifestations of PD, which indicates the connection of cathepsin D with the general pathogenesis of PD. CONCLUSION The possibility of using serum proteins of the neurotrophin subfamily and the protein associated with autophagy, cathepsin D, as biomarkers that determine the prognosis of PD, is considered.

1 January 2016 in Social Aspects of Population Health
Verified
Journal Article
Closed access
OKO.V. Koudelina
O.V. Koudelina
NBN.G. Brazovskaya
N.G. Brazovskaya
???? ??????: ??????????? ????????????, ???????????? ?? ????????????????? ??????? ?????????? ????????? ????????? ? ??????????? ??????????????? ??????? ??????? ?? ?????? ???????? ?????? ????????????? ? ??????.